For establishing a novel hinge derived from human CD34, researchers systematically tested CD34 fragments of different lengths, all containing the binding site of the QBend-10 monoclonal antibody, in a FMC63-based CD19 CAR lentiviral construct.
[Molecular Therapy-Oncolytics]
Sorry, but the selected Zotpress account can't be found.